JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.


Figure 6


FIGURE 6.  18F-DOPA coronal view after carbidopa pretreatment in patient with metastasized carcinoid, showing heterogeneity of receptor expression and metabolic activity. (A) 18F-DOPA PET showing high uptake in entire process. (B) Considerably heterogeneous 111In-octreotide uptake. Apparently, medial part of this tumor (arrows) had lost most of its somatostatin receptor expression while retaining metabolic activity and 18F-DOPA uptake.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE